Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001558370-24-004621
Filing Date
2024-04-02
Accepted
2024-04-02 17:06:03
Documents
75

Document Format Files

Seq Description Document Type Size
1 S-1/A sngx-20231231xs1a.htm   iXBRL S-1/A 2842429
2 EX-23.1 sngx-20231231xex23d1.htm EX-23.1 5329
3 EX-23.2 sngx-20231231xex23d2.htm EX-23.2 5477
4 GRAPHIC sngx-20231231xs1a001.jpg GRAPHIC 6865
5 GRAPHIC sngx-20231231xs1a009.jpg GRAPHIC 784
6 GRAPHIC sngx-20231231xs1a010.jpg GRAPHIC 796
7 GRAPHIC sngx-20231231xs1a025.jpg GRAPHIC 3974
  Complete submission text file 0001558370-24-004621.txt   9791480

Data Files

Seq Description Document Type Size
8 EX-101.SCH sngx-20231231.xsd EX-101.SCH 63080
9 EX-101.CAL sngx-20231231_cal.xml EX-101.CAL 62577
10 EX-101.DEF sngx-20231231_def.xml EX-101.DEF 293028
11 EX-101.LAB sngx-20231231_lab.xml EX-101.LAB 564040
12 EX-101.PRE sngx-20231231_pre.xml EX-101.PRE 443022
79 EXTRACTED XBRL INSTANCE DOCUMENT sngx-20231231xs1a_htm.xml XML 1435523
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

EIN.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-276511 | Film No.: 24815427
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)